Consequently, we hypothesize that ROCK1 serves as a critical molecular mediator in the upregulation of PD‐L1 by IBA, where IBA binds to and activates ROCK1, thereby triggering the downstream c‐Myc/PD‐L1 pathway and ultimately affecting the tumor immune microenvironment. The gene discussed is ROCK1; the disease is neoplasm.